2012 Aarkstore.com || Biomay AG – Product Pipeline Review – 2012

Document Sample
2012 Aarkstore.com || Biomay AG – Product Pipeline Review – 2012 Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Biomay AG – Product Pipeline Review – 2012



More about this report


You can also request for sample page of above mention reports on
sample@aarkstore.com



Summary

Global Markets Direct’s pharmaceuticals report, “Biomay AG - Product Pipeline
Review - 2012” provides data on the Biomay AG’s research and development focus.
The report includes information on current developmental pipeline, complete with
latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Biomay AG’s corporate website, SEC filings, investor
presentations and featured press releases, both from Biomay AG and industry-
specific third party sources, put together by Global Markets Direct’s team.

Scope

- Biomay AG - Brief Biomay AG overview including business description, key
information and facts, and its locations and subsidiaries.
- Review of current pipeline of Biomay AG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.

Table of contents:
List of Tables 5
List of Figures 5
Biomay AG Snapshot 6
Biomay AG Overview 6
Key Information 6
Key Facts 6
Biomay AG – Research and Development Overview 7
Key Therapeutic Areas 7
Biomay AG – Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products – Monotherapy 11
Biomay AG – Pipeline Products Glance 12
Biomay AG Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Biomay AG – Early Stage Pipeline Products 13
Pre-Clinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Biomay AG – Drug Profiles 15
Birch Allergen RNA Vaccine 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Birch Allergen Specific IgG 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Birch Pollen Allergen Peptide Carrier Fusion Vaccine 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
BM32 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Cat Allergen Hypoallergenic Vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Cat Allergen Peptide Carrier Fusion Vaccine 21
Product Description 21
Mechanism of Action 21




List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1




NOXXON Pharma AG – Product Pipeline Review – 2012

Proacta, Inc. – Product Pipeline Review – 2012

Thrasos, Inc. – Product Pipeline Review – 2012

Wellstat Therapeutics Corporation – Product Pipeline Review – 2012

Biomay AG – Product Pipeline Review – 2012

Cell Therapeutics, Inc. – Product Pipeline Review – 2012

Cortex Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Genmab A/S – Product Pipeline Review – 2012

Genocea Biosciences, Inc. – Product Pipeline Review – 2012

Halozyme Therapeutics, Inc. – Product Pipeline Review – 2012



Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:2
posted:9/27/2012
language:
pages:4